Navigation path

Horizon Prizes

Take a look at the Horizon Prizes web site to see which challenge you might take up ...

• Better use of Antibiotics • Breaking the optical transmission barriers
• Materials for clean air • Collaborative Spectrum Sharing • Food scanner

World Cancer Day 2015: EU Research to Fight Cancer

Cancer is the second most common cause of death in Europe, with about 3.2 million citizens diagnosed with cancer each year.

Where does the EU come into the picture? To mark World Cancer Day 2015 (4 February), here is a quick look at what the EU is doing in the field of cancer research.

 

The EU invests over €200 million per year in cancer research.

The EU is an important cancer research funder. During the past seven years, the EU has invested more than €1.4 billion in international collaborative research, frontier research, mobility programmes, public-private partnerships and coordination of national cancer research efforts.

More than half this budget - € 770 million - has been used to encourage key players from across Europe and beyond to join forces in 'collaborative research projects', to find new ways to fight cancer and help patients. These projects help us better understand how various types of cancer develop, how they can be diagnosed earlier and treated more successfully.

For instance, the EU-funded RATHER project is delivering a proof-of-concept for novel therapeutic interventions, together with matched personalised diagnostic approaches for 'triple negative' and 'invasive lobular' breast cancers. RATHER has initiated a phase I/II clinical trial to examine patient responses to a novel drug in a clinical setting.

The application of nanotechnology in medicine (nanomedicine) also creates new opportunities for early diagnosis and therapy of cancer. The EU-funded projects NAMDIATREAM and SaveMe develop nanotechnology-based diagnosis and therapy for cancer.

Clinical trials to validate new cancer medicines and treatments are also at the core of the EUROSARC network, which focuses on rare malignant tumours affecting soft- and bone tissues. For this project, working across the whole of Europe is the only way to recruit enough patients in a reasonable timeframe to carry out the tests, something that would not have been possible for one individual country.

Here are two examples of successful, EU-funded cancer research projects:

Picture of the radiology technician at work

Personalising breast cancer screening

Breast cancer is a leading cause of death for women, despite screening programmes cutting mortality rates. EU-funded researchers have developed new tools for personalised screening programmes to improve detection and prognosis - several of which are ready for use.

Picture of woman presenting breast cancer awareness message

Targeting the drivers of difficult-to-treat breast cancers

One quarter of breast cancer cases belong to two subtypes that are difficult to treat. EU-funded researchers are identifying new therapeutic targets for these patient groups. The research has already led to new diagnostic tools, while patients are already being enrolled for clinical trials.

 

Read more cancer research success stories